Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | ACLX |
---|---|---|
09:32 ET | 7173 | 51.7788 |
09:34 ET | 1100 | 53.27 |
09:36 ET | 500 | 53.49 |
09:38 ET | 1793 | 53.96 |
09:39 ET | 535 | 53.96 |
09:41 ET | 935 | 54.25 |
09:43 ET | 500 | 54.23 |
09:45 ET | 1000 | 54 |
09:48 ET | 600 | 53.885 |
09:50 ET | 800 | 54.1 |
09:52 ET | 7600 | 53.98 |
09:54 ET | 2699 | 53.965 |
09:56 ET | 2877 | 53.96 |
09:57 ET | 300 | 54 |
09:59 ET | 15592 | 54.0875 |
10:01 ET | 3742 | 53.775 |
10:03 ET | 1500 | 53.845 |
10:06 ET | 327 | 53.86 |
10:08 ET | 100 | 54 |
10:10 ET | 1100 | 53.925 |
10:12 ET | 1600 | 53.97 |
10:14 ET | 3619 | 53.73 |
10:15 ET | 2171 | 53.83 |
10:17 ET | 1550 | 53.55 |
10:19 ET | 200 | 53.7404 |
10:21 ET | 585 | 53.64 |
10:24 ET | 800 | 53.5 |
10:26 ET | 1386 | 53.37 |
10:28 ET | 300 | 53.195 |
10:30 ET | 1401 | 53.09 |
10:32 ET | 100 | 53.035 |
10:33 ET | 443 | 53.035 |
10:35 ET | 5622 | 53.39 |
10:37 ET | 400 | 53.44 |
10:39 ET | 477 | 53.365 |
10:42 ET | 300 | 53.49 |
10:44 ET | 400 | 53.255 |
10:46 ET | 300 | 53.36 |
10:48 ET | 521 | 53.38 |
10:50 ET | 2841 | 53.62 |
10:51 ET | 314 | 53.63 |
10:53 ET | 400 | 53.45 |
10:55 ET | 2109 | 53.635 |
10:57 ET | 100 | 53.665 |
11:00 ET | 800 | 53.735 |
11:02 ET | 4301 | 53.57 |
11:04 ET | 3220 | 53.59 |
11:06 ET | 2984 | 53.585 |
11:08 ET | 200 | 53.56 |
11:09 ET | 15802 | 53.69 |
11:11 ET | 1393 | 53.61 |
11:13 ET | 100 | 53.665 |
11:15 ET | 646 | 53.7538 |
11:18 ET | 1956 | 53.64 |
11:20 ET | 433 | 53.73 |
11:22 ET | 100 | 53.67 |
11:24 ET | 10165 | 53.91 |
11:26 ET | 13415 | 53.725 |
11:29 ET | 1999 | 53.85 |
11:31 ET | 800 | 54 |
11:33 ET | 5568 | 53.87 |
11:36 ET | 800 | 53.87 |
11:38 ET | 1787 | 53.85 |
11:40 ET | 2408 | 53.59 |
11:42 ET | 700 | 53.65 |
11:44 ET | 400 | 53.725 |
11:45 ET | 12400 | 53.66 |
11:47 ET | 20500 | 53.61 |
11:49 ET | 2319 | 53.38 |
11:51 ET | 2251 | 53.07 |
11:54 ET | 1100 | 53.105 |
11:56 ET | 4200 | 53.15 |
11:58 ET | 3000 | 53.135 |
12:00 ET | 200 | 53.07 |
12:02 ET | 1531 | 53.09 |
12:03 ET | 1300 | 53.09 |
12:05 ET | 1025 | 52.96 |
12:07 ET | 670 | 52.755 |
12:09 ET | 1000 | 52.86 |
12:12 ET | 1000 | 52.84 |
12:14 ET | 972 | 52.75 |
12:16 ET | 700 | 52.74 |
12:18 ET | 600 | 52.68 |
12:20 ET | 2900 | 52.575 |
12:21 ET | 18468 | 53.115 |
12:23 ET | 3379 | 53.075 |
12:25 ET | 3179 | 53.015 |
12:27 ET | 1627 | 52.8 |
12:30 ET | 1300 | 52.745 |
12:32 ET | 3215 | 52.805 |
12:34 ET | 2400 | 52.52 |
12:36 ET | 480 | 52.49 |
12:38 ET | 1194 | 52.48 |
12:39 ET | 300 | 52.46 |
12:41 ET | 1800 | 52.655 |
12:43 ET | 733 | 52.63 |
12:45 ET | 1300 | 52.77 |
12:48 ET | 3449 | 52.55 |
12:50 ET | 600 | 52.7525 |
12:52 ET | 200 | 52.55 |
12:54 ET | 500 | 52.63 |
12:56 ET | 2412 | 52.6931 |
12:57 ET | 2295 | 52.7 |
12:59 ET | 716 | 52.63 |
01:01 ET | 600 | 52.61 |
01:03 ET | 1127 | 52.47 |
01:06 ET | 300 | 52.47 |
01:08 ET | 800 | 52.56 |
01:10 ET | 1200 | 52.265 |
01:12 ET | 100 | 52.26 |
01:14 ET | 500 | 52.18 |
01:15 ET | 2900 | 52.195 |
01:17 ET | 2302 | 52.43 |
01:19 ET | 600 | 52.415 |
01:21 ET | 100 | 52.49 |
01:24 ET | 504 | 52.415 |
01:26 ET | 1002 | 52.31 |
01:28 ET | 900 | 52.39 |
01:30 ET | 2432 | 52.39 |
01:32 ET | 1100 | 52.38 |
01:33 ET | 1300 | 52.415 |
01:35 ET | 700 | 52.315 |
01:37 ET | 2400 | 52.29 |
01:39 ET | 200 | 52.35 |
01:42 ET | 800 | 52.42 |
01:44 ET | 2573 | 52.58 |
01:46 ET | 300 | 52.535 |
01:48 ET | 100 | 52.5575 |
01:50 ET | 1200 | 52.75 |
01:51 ET | 2897 | 52.49 |
01:55 ET | 900 | 52.4 |
01:57 ET | 2003 | 52.52 |
02:00 ET | 1300 | 52.51 |
02:02 ET | 200 | 52.505 |
02:04 ET | 450 | 52.535 |
02:06 ET | 1105 | 52.58 |
02:08 ET | 1525 | 52.47 |
02:09 ET | 300 | 52.475 |
02:13 ET | 300 | 52.48 |
02:15 ET | 4357 | 52.51 |
02:18 ET | 400 | 52.495 |
02:20 ET | 1755 | 52.63 |
02:22 ET | 500 | 52.58 |
02:24 ET | 200 | 52.58 |
02:26 ET | 1883 | 52.37 |
02:27 ET | 100 | 52.32 |
02:29 ET | 200 | 52.18 |
02:31 ET | 1000 | 51.96 |
02:33 ET | 598 | 51.96 |
02:36 ET | 984 | 51.88 |
02:38 ET | 600 | 52.02 |
02:40 ET | 500 | 51.86 |
02:42 ET | 700 | 51.86 |
02:44 ET | 1307 | 51.77 |
02:45 ET | 400 | 51.74 |
02:47 ET | 1800 | 51.75 |
02:49 ET | 1813 | 51.7 |
02:51 ET | 800 | 51.75 |
02:54 ET | 400 | 51.765 |
02:56 ET | 1338 | 51.69 |
02:58 ET | 100 | 51.65 |
03:00 ET | 1209 | 51.6 |
03:02 ET | 2230 | 51.555 |
03:03 ET | 200 | 51.525 |
03:05 ET | 2800 | 51.395 |
03:07 ET | 1300 | 51.36 |
03:09 ET | 500 | 51.36 |
03:12 ET | 1248 | 51.51 |
03:14 ET | 1000 | 51.555 |
03:16 ET | 300 | 51.56 |
03:18 ET | 415 | 51.52 |
03:20 ET | 2267 | 51.4 |
03:21 ET | 546 | 51.37 |
03:23 ET | 1389 | 51.405 |
03:25 ET | 805 | 51.35 |
03:27 ET | 1400 | 51.3 |
03:30 ET | 200 | 51.3 |
03:32 ET | 1900 | 51.28 |
03:34 ET | 2904 | 51.295 |
03:36 ET | 200 | 51.29 |
03:38 ET | 2207 | 51.33 |
03:39 ET | 2000 | 51.45 |
03:41 ET | 2300 | 51.51 |
03:43 ET | 500 | 51.555 |
03:45 ET | 2600 | 51.85 |
03:48 ET | 3042 | 51.86 |
03:50 ET | 1100 | 51.88 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Arcellx Inc | 2.7B | -49.9x | --- |
Rhythm Pharmaceuticals Inc | 2.5B | -8.6x | --- |
Merus NV | 2.6B | -16.6x | --- |
Intellia Therapeutics Inc | 2.5B | -4.9x | --- |
Avidity Biosciences Inc | 2.8B | -10.0x | --- |
Recursion Pharmaceuticals Inc | 2.4B | -6.2x | --- |
Arcellx, Inc. is a clinical-stage biotechnology company. The Company is focused on the development of controllable cell therapies for the treatment of patients with cancer and other incurable diseases. The Company’s lead program is a BCMA-targeting ddCAR product candidate called CART-ddBCMA, which is being evaluated in its pivotal Phase II iMMagine-1 trial in patients with relapsed or refractory multiple myeloma (rrMM). The Company is also developing two clinical-stage ARC-SparX programs in Phase I trials; ACLX-001, which targets BCMA in rrMM, and ACLX-002, which targets CD123 in relapsed or refractory acute myeloid leukemia (AML) and high-risk myelodysplastic syndrome (MDS). Outside of multiple myeloma (MM), the Company advances its wholly owned portfolio of clinical-stage, ACLX-002, and preclinical pipeline programs incorporating its D-Domain technology. D-Domain, is designed to overcome the limitations of traditional Chimeric Antigen Receptor T-cells (CAR-Ts).
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $2.7B |
---|---|
Revenue (TTM) | $131.7M |
Shares Outstanding | 53.3M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | --- |
EPS | $-1.04 |
Book Value | $9.28 |
P/E Ratio | -49.9x |
Price/Sales (TTM) | 20.5 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -57.14% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.